DYN Financial Statements

Balance sheet, income statement, cash flow, and dividends for Dyne Therapeutics Inc (DYN).


$2.40B Market Cap.

As of 02/27/2025 5:00 PM ET (MRY) • Disclaimer

DYN Market Cap. (MRY)


DYN Shares Outstanding (MRY)


DYN Assets (MRY)


Total Assets

$691.23M

Total Liabilities

$61.40M

Total Investments

$206.82M

DYN Income (MRY)


Revenue

$0

Net Income

-$317.42M

Operating Expense

$343.89M

DYN Cash Flow (MRY)


CF Operations

-$292.37M

CF Investing

-$204.08M

CF Financing

$809.89M

DYN Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

DYN Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$691,234,000 (318.72%)

$165,082,000 (-46.11%)

$306,325,000 (-28.04%)

$425,663,000 (20.47%)

Assets Current

$659,279,000 (409.59%)

$129,375,000 (-51.29%)

$265,594,000 (-30.54%)

$382,392,000 (9.54%)

Assets Non-Current

$31,955,000 (-10.51%)

$35,707,000 (-12.33%)

$40,731,000 (-5.87%)

$43,271,000 (918.86%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$629,838,000 (589.92%)

$91,292,000 (-63.83%)

$252,364,000 (-31.46%)

$368,197,000 (7.54%)

Property Plant & Equipment Net

$30,013,000 (-10.12%)

$33,392,000 (-13.07%)

$38,412,000 (-6.22%)

$40,960,000 (2004.83%)

Cash & Equivalents

$437,391,000 (252.90%)

$123,941,000 (-28.96%)

$174,466,000 (-14.11%)

$203,136,000 (-32.48%)

Accumulated Other Comprehensive Income

$6,000 (0%)

$0 (0%)

-$571,000 (-112.27%)

-$269,000 (-896.30%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$206,819,000 (13931.14%)

$1,474,000 (-98.24%)

$83,865,000 (-52.28%)

$175,746,000 (295.27%)

Investments Current

$206,819,000 (13931.14%)

$1,474,000 (-98.24%)

$83,865,000 (-52.28%)

$175,746,000 (295.27%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$6,562,000 (-71.39%)

$22,936,000 (336.13%)

$5,259,000 (30.46%)

$4,031,000 (17.18%)

Accumulated Retained Earnings (Deficit)

-$949,928,000 (-50.18%)

-$632,510,000 (-59.49%)

-$396,573,000 (-73.57%)

-$228,474,000 (-188.54%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$23,988,000 (-12.50%)

$27,415,000 (-10.06%)

$30,483,000 (-6.60%)

$32,636,000 (0%)

Debt Current

$4,850,000 (2.75%)

$4,720,000 (2.39%)

$4,610,000 (18.42%)

$3,893,000 (0%)

Debt Non-Current

$19,138,000 (-15.67%)

$22,695,000 (-12.28%)

$25,873,000 (-9.99%)

$28,743,000 (0%)

Total Liabilities

$61,396,000 (-16.80%)

$73,790,000 (36.75%)

$53,961,000 (-6.10%)

$57,466,000 (423.99%)

Liabilities Current

$42,258,000 (-17.30%)

$51,095,000 (81.91%)

$28,088,000 (-2.21%)

$28,723,000 (161.90%)

Liabilities Non-Current

$19,138,000 (-15.67%)

$22,695,000 (-12.28%)

$25,873,000 (-9.99%)

$28,743,000 (0%)

DYN Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$62,480,000 (98.98%)

$31,400,000 (11.34%)

$28,202,000 (-1.79%)

$28,717,000 (113.56%)

Research & Development Expense

$281,406,000 (33.52%)

$210,762,000 (47.63%)

$142,760,000 (17.68%)

$121,308,000 (168.38%)

Operating Expenses

$343,886,000 (42.01%)

$242,162,000 (41.65%)

$170,962,000 (13.96%)

$150,025,000 (155.81%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$317,418,000 (-34.54%)

-$235,937,000 (-40.36%)

-$168,099,000 (-12.60%)

-$149,291,000 (-151.18%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$317,418,000 (-34.54%)

-$235,937,000 (-40.36%)

-$168,099,000 (-12.60%)

-$149,291,000 (-151.18%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$317,418,000 (-34.54%)

-$235,937,000 (-40.36%)

-$168,099,000 (-12.60%)

-$149,291,000 (-151.18%)

Weighted Average Shares

$94,143,565 (57.74%)

$59,683,851 (14.83%)

$51,976,343 (2.12%)

$50,895,044 (253.54%)

Weighted Average Shares Diluted

$94,143,565 (57.74%)

$59,683,851 (14.83%)

$51,976,343 (2.12%)

$50,895,044 (253.54%)

Earning Before Interest & Taxes (EBIT)

-$317,418,000 (-34.54%)

-$235,937,000 (-40.36%)

-$168,099,000 (-12.60%)

-$149,291,000 (-152.86%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$343,886,000 (-42.01%)

-$242,162,000 (-41.65%)

-$170,962,000 (-13.96%)

-$150,025,000 (-155.81%)

DYN Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$204,076,000 (-344.96%)

$83,311,000 (-4.46%)

$87,202,000 (163.24%)

-$137,892,000 (-201.99%)

Net Cash Flow from Financing

$809,895,000 (1390.92%)

$54,322,000 (45.28%)

$37,390,000 (-76.31%)

$157,821,000 (-58.54%)

Net Cash Flow from Operations

-$292,369,000 (-55.38%)

-$188,158,000 (-22.46%)

-$153,645,000 (-28.51%)

-$119,563,000 (-157.08%)

Net Cash Flow / Change in Cash & Cash Equivalents

$313,450,000 (720.39%)

-$50,525,000 (-73.91%)

-$29,053,000 (70.84%)

-$99,634,000 (-134.53%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$201,700,000 (-340.00%)

$84,040,000 (-6.90%)

$90,269,000 (167.23%)

-$134,274,000 (-201.74%)

Capital Expenditure

-$2,376,000 (-225.93%)

-$729,000 (76.23%)

-$3,067,000 (15.23%)

-$3,618,000 (-211.63%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$809,895,000 (1390.92%)

$54,322,000 (45.28%)

$37,390,000 (-76.31%)

$157,821,000 (-35.95%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$45,864,000 (129.64%)

$19,972,000 (31.59%)

$15,178,000 (-13.48%)

$17,542,000 (166.15%)

Depreciation Amortization & Accretion

$2,243,000 (-8.86%)

$2,461,000 (-26.43%)

$3,345,000 (878.07%)

$342,000 (-51.14%)

DYN Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-49.00% (64.08%)

-136.40% (-128.48%)

-59.70% (-71.06%)

-34.90% (-4.49%)

Return on Average Assets (ROAA)

-45.20% (56.41%)

-103.70% (-105.75%)

-50.40% (-56.04%)

-32.30% (-0.62%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-138.60% (57.06%)

-322.80% (-263.51%)

-88.80% (-24.54%)

-71.30% (75.27%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-6.99 (-107.63%)

-3.37 (6.16%)

-3.59 (11.58%)

-4.06 (20.20%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

3.81 (-57.43%)

8.94 (273.52%)

2.39 (43.87%)

1.66 (-40.29%)

Debt to Equity Ratio (D/E)

0.1 (-88.00%)

0.81 (277.57%)

0.21 (37.18%)

0.16 (387.50%)

Earnings Per Share (EPS)

-3.37 (14.68%)

-3.95 (-22.29%)

-3.23 (-10.24%)

-2.93 (29.06%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-3.13 (1.07%)

-3.17 (-4.98%)

-3.02 (-24.59%)

-2.42 (26.91%)

Book Value Per Share (BVPS)

6.69 (337.25%)

1.53 (-68.49%)

4.86 (-32.89%)

7.23 (-69.58%)

Tangible Assets Book Value Per Share (TABVPS)

7.34 (165.44%)

2.77 (-53.07%)

5.89 (-29.53%)

8.36 (-65.92%)

Enterprise Value Over EBIT (EV/EBIT)

-6 (-100.00%)

-3 (0.00%)

-3 (0.00%)

-3 (70.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-5.99 (-96.49%)

-3.05 (-2.42%)

-2.98 (-6.17%)

-2.8 (72.02%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

15.6 (516.15%)

2.53 (-73.22%)

9.46 (-28.97%)

13.31 (-58.18%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$294,745,000 (-56.04%)

-$188,887,000 (-20.53%)

-$156,712,000 (-27.22%)

-$123,181,000 (-158.41%)

Enterprise Value (EV)

$1,888,363,970 (165.25%)

$711,918,453 (45.16%)

$490,439,678 (17.43%)

$417,631,496 (-28.57%)

Earnings Before Tax (EBT)

-$317,418,000 (-34.54%)

-$235,937,000 (-40.36%)

-$168,099,000 (-12.60%)

-$149,291,000 (-151.18%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$315,175,000 (-34.99%)

-$233,476,000 (-41.71%)

-$164,754,000 (-10.61%)

-$148,949,000 (-155.31%)

Invested Capital

$235,573,000 (1249.14%)

$17,461,000 (-86.99%)

$134,254,000 (-40.71%)

$226,440,000 (445.44%)

Working Capital

$617,021,000 (688.22%)

$78,280,000 (-67.04%)

$237,506,000 (-32.85%)

$353,669,000 (4.60%)

Tangible Asset Value

$691,234,000 (318.72%)

$165,082,000 (-46.11%)

$306,325,000 (-28.04%)

$425,663,000 (20.47%)

Market Capitalization

$2,397,605,970 (193.72%)

$816,295,453 (35.11%)

$604,150,678 (-1.39%)

$612,673,496 (-35.80%)

Average Equity

$647,156,500 (274.00%)

$173,035,500 (-38.51%)

$281,406,500 (-34.30%)

$428,292,250 (140.34%)

Average Assets

$702,060,250 (208.47%)

$227,597,250 (-31.74%)

$333,448,000 (-27.96%)

$462,849,500 (150.34%)

Invested Capital Average

$229,054,500 (213.42%)

$73,081,250 (-61.41%)

$189,374,000 (-9.55%)

$209,361,500 (922.25%)

Shares

101,765,958 (65.81%)

61,375,598 (17.74%)

52,126,892 (1.16%)

51,528,469 (13.39%)